Ixazomib▼: a novel oral proteasome inhibitor
...
Ixazomib▼: a novel oral proteasome inhibitor
...
IL-17A-Inhibitor bei Plaque-Psoriasis
...
IL-17A-Inhibitor bei Plaque-Psoriasis
...
IL-17A-Inhibitor bei Plaque-Psoriasis
...
IL-17A-Inhibitor bei Plaque-Psoriasis
...
IL-17A-Inhibitor bei Plaque-Psoriasis
...
IL-17A-Inhibitor bei Plaque-Psoriasis
...
Invasive aspergillosis and mucormycosis
Isavuconazole (Cresemba®), a triazole antifungal, authorised in the EU since October 2015, demonstrated clinical effectiveness in pivotal trials of invasive aspergillosis and mucormycosis, and a...
Essential Knowledge Briefing: Growth in Early Life: Growth Trajectory and Assessment, Influencing Factors and Impact of Early Nutrition
This Essential Knowledge Briefing practical guide, entitled ‚Growth in Early Life: Growth Trajectory and Assessment, Influencing Factors an d Impact of Early Nutrition‘ provides an...